These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 4623790

  • 21. [Mechanism of action of gliquidone (author's transl)].
    Zilker T, Ermler R, Henderkott U, Bottermann P.
    Dtsch Med Wochenschr; 1975 Aug 29; 100(35):1733-4, 1739-41. PubMed ID: 808405
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E, Beyer J, Schöffling K.
    Dtsch Med Wochenschr; 1974 Mar 01; 99(9):385-8. PubMed ID: 4208186
    [No Abstract] [Full Text] [Related]

  • 24. [Glibenclamide, a new oral antidiabetic].
    Edlén A.
    Lakartidningen; 1972 Jan 19; 69(4):342-3. PubMed ID: 4622487
    [No Abstract] [Full Text] [Related]

  • 25. Progress in oral therapy of diabetes mellitus with sulphonylureas of the second generation.
    Raptis S, Pfeiffer EF.
    Acta Diabetol Lat; 1972 Jan 19; 9(6):865-99. PubMed ID: 4197419
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD.
    Clin Pharm; 1984 Jan 19; 3(5):473-85. PubMed ID: 6435940
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
    Emanueli A, Molari E, Pirola LC, Caputo G.
    Arzneimittelforschung; 1972 Nov 19; 22(11):1881-5. PubMed ID: 4267009
    [No Abstract] [Full Text] [Related]

  • 33. [Preliminary clinical experiences and problems of long-term therapy of diabetes mellitus using 2nd generation sulfonylurea derivatives (glibenclamide)].
    Schilling I, Bruns W, Haller H, Mehnert E, Mohnike A, Jutzi E, Schliack V, Schulze J.
    Z Gesamte Inn Med; 1973 May 15; 28(10):Suppl 10:149-5. PubMed ID: 4200337
    [No Abstract] [Full Text] [Related]

  • 34. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
    Lentini S, Bossini A, Pirola LC.
    Arzneimittelforschung; 1972 Jul 15; 22(7):1169-73. PubMed ID: 4678124
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.